SCHEMBL12424299

SCHEMBL12424299

OCCc1cc(-c2cccs2)sc1-c1ccc(-c2sc(-c3cccs3)cc2CCO)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.49
LTA4H P09960 1/20 0.39
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 5/20 0.37
GAA P10253 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
GLA P06280 2/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
HPGD P15428 2/20 0.36
CASP1 P29466 2/20 0.36
CASP7 P55210 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365923 0.95 DPP4 (0.45) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL9976549 0.84 LTA4H (0.46) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL22343408 0.83 DPP4 (0.50) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL9976553 0.81 LTA4H (0.53) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL6481577 0.81 DPP4 (0.43) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL10062482 0.79 DPP4 (0.48) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL9976552 0.79 ALDH1A1 (0.45) DPP4ALDH1A1KDM4EGAAL3MBTL1
SCHEMBL14646202 0.78 DPP4 (0.45) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL14590760 0.78 SREBF2 (0.37) DPP4LTA4HALDH1A1KDM4EGAA
SCHEMBL20146971 0.77 KDM4E (0.42) DPP4LTA4HALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012656-B2 Oligothiophene derivate as molecular probes CELLUMINOVA AB (SE) 2015-04-21 US disclosed
US-9012656-B2 Oligothiophene derivate as molecular probes CELLUMINOVA AB (SE) 2015-04-21 US disclosed
EP-2536712-B1 OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES CELLUMINOVA AB (SE) 2015-03-18 EP disclosed
US-20120315646-A1 OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES CELLUMINOVA AB (SE) 2012-12-13 US disclosed
US-20120315646-A1 OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES CELLUMINOVA AB (SE) 2012-12-13 US disclosed
WO-2011102789-A1 OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES OBOE IPR AB (SE) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120315646-A1 OLIGOTHIOPHENE DERIVATE AS MOLECULAR PROBES NMT1, DNTT, NOTCH4 DPP4 1879/4885LTA4H 3114/4885ALDH1A1 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.